Controlling microglia hyperactivity is a target for drug discovery efforts that include the γ-secretase inhibitor, CHF5074, designated as a “microglia modulator” and renamed CSP-1103, that reduces biomarkers of neuroinflammation in patients with mild cognitive impairment [159], while inhibition of RI...
2005November ceo 2011 1179 1652 1188 1780 mayhem apc vpnd 1423 Literature rome firewall1 1377 GPL 1599 annualreport emailnewsletters intellectualproperty last100 1357 contacto topicslashdot midi spamcop National 2006May csp 1085 nswpat80x15 genetics stars2 1144 934 csl sexy bypass...